How might your approach to pharma communications shift if you suddenly found yourself on the patient side?

Sara Noonan has dedicated nearly two decades to building patient communications in rare disease and oncology,  holding roles as the Senior Director of Product and Pipeline Communications for Servier Pharmaceuticals and Director of Public Relations and Investor Relations in the oncology business unit at Takeda.

In this episode, Sara joins Kristen to reflect on how becoming a rare disease patient herself has reshaped her thinking about patient education, advocacy, and what it really means to be "patient-centered."